Search

Your search keyword '"Kerneis, M"' showing total 249 results

Search Constraints

Start Over You searched for: Author "Kerneis, M" Remove constraint Author: "Kerneis, M"
249 results on '"Kerneis, M"'

Search Results

1. Phenotyping Coronary Plaque by Computed Tomography in Premature Coronary Artery Disease

2. Ticagrelor or Clopidogrel to reduce ischemic events after Percutaneous Coronary Intervention in chronic coronary syndrome in clopidogrel naive patient: The ALPHEUS Naive sub-study

4. Incidence and determinants of non-radial vascular approach for coronary angiography among heart transplant recipients

5. Ticagrelor or Clopidogrel to reduce ischemic events after Percutaneous Coronary Intervention in chronic coronary syndrome in clopidogrel naive patient: the ALPHEUS Naive sub-study

8. Early versus delayed introduction of renin angiotensin aldosterone system inhibitors in cardiogenic shock

9. Synergistic effect of Interleukin-1beta and cholesterol efflux capacity on outcomes in acute myocardial infarction patients

12. Reduced capacity of HDL to acquire free cholesterol upon lipolysis of triglyceride-rich lipoproteins reflects severity of myocardial infarction

13. Prevalence, Characteristics, and Outcomes of COVID-19-Associated Acute Myocarditis

15. Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry

16. Comparison of the safety and efficacy of antithrombotic regimens following TAVR in patients without having an indication for chronic oral anticoagulation

18. Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry

19. Myocardites fulminantes associées aux auto-anticorps Anti-ARN-polymérases III

20. Hétérogénéité phénotypique des myocardites fulminantes induites par la COVID-19 chez l’adulte

21. Combinatorial, additive and dose-dependent drug-microbiome associations

24. T1 mapping-derived signature of myocardial involvement in idiopathic inflammatory myopathy compared to acute viral myocarditis: a texture-based analysis

25. Interleukin-1Beta and risk of premature death and MACE in patients with myocardial infarction

26. Early aspirin discontinuation following acute coronary syndrome or percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials

27. Antithrombotic therapy and cardiovascular events in patients with left ventricular thrombus

30. Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial Fibrillation: Insights From the PIONEER AF-PCI Trial

31. Association of International Normalized Ratio Stability and Bleeding Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention

32. The chronic ischaemic cardiovascular disease ESC Pilot Registry: Results of the six-month follow-up

33. P961Investigator versus Core Lab evaluation of coronary blood flow in PCI of patients in cardiogenic shock: a substudy of the CULPRIT-SHOCK trial

35. P6454Antithrombotic therapy and cardiovascular events in patients with left ventricular thrombus

38. Platelet function monitoring for the prediction of clinical outcomes: A pooled analysis of the randomized ARCTIC and ANTARCTIC trials

39. Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights From the PIONEER AF-PCI Trial

40. Safety and efficacy of non-vitamin K oral anticoagulant for atrial fibrillation patients after percutaneous coronary intervention: A bivariate analysis of the PIONEER AF-PCI and RE-DUAL PCI trial

41. Total bleeding with rivaroxaban versus warfarin in patients with atrial fibrillation receiving antiplatelet therapy after percutaneous coronary intervention

42. 2160Performance of a machine learning model vs. IMPROVE score for VTE prediction in acute medically ill patients: insights from the APEX trial

43. P5139Identification of atrial fibrillation patients who are at high bleeding risk after undergoing percutaneous coronary intervention: insights from the PIONEER AF-PCI trial

44. P6072Characterization of major and clinically relevant non-major bleeding in the APEX trial

45. 109Betrixaban compared to enoxaparin among obese acute medically ill subjects: an APEX trial subgroup analysis

46. 1460Effect of the INR stability characteristics on bleeding events among atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the PIONEER AF-PCI trial

48. A prospective cardiometabolism ApPRoach of mechanisms of coronary plaque rupture to apprehend patients at risk of recurrent events — The APPROACH registry

50. 2050Impact on clinical outcome of on-treatment platelet reactivity according to concordant platelet function tests: the multi-test platelet function study

Catalog

Books, media, physical & digital resources